...
首页> 外文期刊>BMC Cancer >A novel approach for rapid screening of mitochondrial D310 polymorphism
【24h】

A novel approach for rapid screening of mitochondrial D310 polymorphism

机译:快速筛选线粒体D310多态性的新方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Mutations in the mitochondrial DNA (mtDNA) have been reported in a wide variety of human neoplasms. A polynucleotide tract extending from 303 to 315 nucleotide positions (D310) within the non-coding region of mtDNA has been identified as a mutational hotspot of primary tumors. This region consists of two polycytosine stretches interrupted by a thymidine nucleotide. The number of cytosines at the first and second stretches are 7 and 5 respectively, according to the GeneBank sequence. The first stretch exhibits a polymorphic length variation (6-C to 9-C) among individuals and has been investigated in many cancer types. Large-scale studies are needed to clarify the relationship between cytosine number and cancer development/progression. However, time and money consuming methods such as radioactivity-based gel electrophoresis and sequencing, are not appropriate for the determination of this polymorphism for large case-control studies. In this study, we conducted a rapid RFLP analysis using a restriction enzyme, BsaXI, for the single step simple determination of 7-C carriers at the first stretch in D310 region. Methods 25 colorectal cancer patients, 25 breast cancer patients and 41 healthy individuals were enrolled into the study. PCR amplification followed by restriction enzyme digestion of D310 region was performed for RFLP analysis. Digestion products were analysed by agarose gel electrophoresis. Sequencing was also applied to samples in order to confirm the RFLP data. Results Samples containing 7-C at first stretch of D310 region were successfully determined by the BsaXI RFLP method. Heteroplasmy and homoplasmy for 7-C content was also determined as evidenced by direct sequencing. Forty-one percent of the studied samples were found to be BsaXI positive. Furthermore, BsaXI status of colorectal cancer samples were significantly different from that of healthy individuals. Conclusion In conclusion, BsaXI RFLP analysis is a simple and rapid approach for the single step determination of D310 polymorphism of mitochondrial DNA. This method allows the evaluation of a significant proportion of samples without the need for sequencing- and/or radioactivity-based techniques.
机译:背景技术线粒体DNA(mtDNA)中的突变已在多种人类肿瘤中报道。从mtDNA非编码区域内的303到315个核苷酸位置(D310)延伸的多核苷酸束已被鉴定为原发性肿瘤的突变热点。该区域由被胸苷核苷酸打断的两个多胞嘧啶片段组成。根据GeneBank序列,在第一和第二延伸的胞嘧啶的数目分别为7和5。第一段在个体之间表现出多态性长度变化(6-C至9-C),并且已经在许多癌症类型中进行了研究。需要进行大规模研究来阐明胞嘧啶数量与癌症发展/进展之间的关系。但是,对于大型病例对照研究而言,诸如基于放射性的凝胶电泳和测序之类的时间和金钱消耗方法不适用于确定这种多态性。在这项研究中,我们使用限制性内切酶BsaXI进行了快速RFLP分析,以便在D310区的第一个片段上一步一步确定7-C载体。方法招募25例结直肠癌患者,25例乳腺癌患者和41例健康个体。进行PCR扩增,然后限制性酶切D310区域以进行RFLP分析。通过琼脂糖凝胶电泳分析消化产物。测序也应用于样品以确认RFLP数据。结果通过BsaXI RFLP方法成功地测定了D310区域第一段中含有7-C的样品。如直接测序所证实的,还确定了7-C含量的异质和同质。研究样本中有41%被发现是BsaXI阳性。此外,大肠癌样本的BsaXI状况与健康个体明显不同。结论总之,BsaXI RFLP分析是一种简单快速的方法,可用于一步测定线粒体DNA D310多态性。这种方法无需使用基于测序和/或放射性的技术就可以评估很大一部分样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号